122 related articles for article (PubMed ID: 23595589)
1. The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.
Lin JH; Novakovic D; Rizzo CM; Zagorac B; Garand M; Filipieva A; Koschinsky ML; Boffa MB
Thromb Haemost; 2013 Jun; 109(6):1033-44. PubMed ID: 23595589
[TBL] [Abstract][Full Text] [Related]
2. Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells.
Lin JH; Garand M; Zagorac B; Schadinger SL; Scipione C; Koschinsky ML; Boffa MB
Thromb Haemost; 2011 Jun; 105(6):999-1009. PubMed ID: 21505719
[TBL] [Abstract][Full Text] [Related]
3. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.
Garand M; Lin JH; Hill CE; Zagorac B; Koschinsky ML; Boffa MB
Cytokine; 2012 Mar; 57(3):389-97. PubMed ID: 22217421
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the CPB2 gene are maintained by balancing selection and result in haplotype-preferential splicing of exon 7.
Cagliani R; Fumagalli M; Riva S; Pozzoli U; Fracassetti M; Bresolin N; Comi GP; Sironi M
Mol Biol Evol; 2010 Aug; 27(8):1945-54. PubMed ID: 20237223
[TBL] [Abstract][Full Text] [Related]
7. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
Masuda Y; Yazawa J; Makino Y; Takada K
Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).
Boffa MB; Reid TS; Joo E; Nesheim ME; Koschinsky ML
Biochemistry; 1999 May; 38(20):6547-58. PubMed ID: 10350473
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.
Masuda Y; Saotome D; Takada K; Sugimoto K; Sasaki T; Ishii H
Thromb Haemost; 2012 Jul; 108(1):74-85. PubMed ID: 22535242
[TBL] [Abstract][Full Text] [Related]
10. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
Boffa MB; Koschinsky ML
Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
[TBL] [Abstract][Full Text] [Related]
11. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
Bouma BN; Mosnier LO
Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
[TBL] [Abstract][Full Text] [Related]
12. Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor.
Buelens K; Hillmayer K; Compernolle G; Declerck PJ; Gils A
Circ Res; 2008 Feb; 102(3):295-301. PubMed ID: 18063813
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
14. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
15. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mouse thrombin-activatable fibrinolysis inhibitor.
Marx PF; Wagenaar GT; Reijerkerk A; Tiekstra MJ; van Rossum AG; Gebbink MF; Meijers JC
Thromb Haemost; 2000 Feb; 83(2):297-303. PubMed ID: 10739389
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter.
Garand M; Bastajian N; Nesheim ME; Boffa MB; Koschinsky ML
Br J Haematol; 2007 Jul; 138(2):231-44. PubMed ID: 17593031
[TBL] [Abstract][Full Text] [Related]
19. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
Stasko J; Hudecek J; Kubisz P
Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
[TBL] [Abstract][Full Text] [Related]
20. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
